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Hemangiopericitoma de órbita
ABSTRACT
Hemangiopericytomas are rare tumors arising from the proliferation of pericytes. They 
may be found in the lungs, bones, skull, deep soft tissue or limbs. The tumor has an 
unpredictable prognosis and when it affects the orbital region, may have an aggressive 
behavior, with high incidence of recurrence. We report a case of orbital hemangiope-
ricytoma and highlight clinical, surgical, and histopathological features of these tumors. 
Orbital hemangiopericytomas usually are solid, slow-growing tumors. They should be 
considered in the differential diagnosis of well-defined orbital masses along with epi-
dermoid cysts, schwannomas, neurofibromas, fibrous histiocytomas, lipomas, and vas -
cular malformations. The diagnosis is confirmed by anatomopathologic examination and 
sometimes complemented by immunohistochemistry. Complete excision of the tumor 
with wide margins is usually curative; however, radiotherapy and chemotherapy may be 
required for recurrent lesions.
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RESUMO
Hemangiopericitomas são tumores raros originados a partir da proliferação de pericitos, 
ou seja, células que envolvem os capilares. São encontrados em ossos, pulmões, crânio, 
partes moles profundas ou membros inferiores, principalmente na coxa. É considerado 
um tumor com potencial de malignidade incerto e quando afeta a região orbitária pode 
apresentar um comportamento biológico agressivo, com grande chance de recidiva. O 
ob jetivo deste trabalho é relatar um caso de hemangiopericitoma orbital e destacar suas 
características clínicas, cirúrgicas e histopatológicas. Usualmente, os hemangioperici-
tomas da órbita são tumores sólidos, únicos e de crescimento lento. Devem ser lembra dos 
no diagnóstico diferencial dos tumores orbitários bem delimitados, como cistos epi-
dermoides, schwannomas, neurofibromas, fibro-histiocitomas, lipomas e malformações 
vas culares. A confirmação diagnóstica é realizada pelo exame anatomopatológico e, por 
vezes, complementada pelo estudo imuno-histoquímico. O tratamento deve ser realizado 
com exérese completa do tumor, com margens amplas, sendo a radioterapia e a quimio-
terapia reservadas para casos de lesões reincidentes.
Descritores: Hemangiopericitoma. Neoplasias de tecido vascular. Órbita/cirurgia.
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INTRODUCTION
Hemangiopericytomas are rare tumors that develop due 
to the proliferation of pericytes, i.e., the cells that surround 
the capillaries. They were originally described by Stout and 
Murray1 in 1942, and account for approximately 1% of vas -
cular tumors. Intraorbital hemangiopericytomas are even 
less common, with an incidence of 0.8–3%2.
Hemangiopericytomas can be found in the bones, lungs, 
and even the skull, but the majority of these tumors origi-
nate in the deep soft tissues or lower limbs, especially in the 
thighs. Although it may behave like a benign tumor, it has an 
uncertain malignant potential and when it affects the orbital 
region presents potentially aggressive biological behavior, 
with high chance of relapse. There are reports of relapses up 
to 18 months after surgical resection3. 
The objective of this paper is to report a case of orbital 
hemangiopericytoma and to highlight this tumor’s clinical, 
surgical, and histopathological features.
CASE REPORT
 A 70-year-old woman presented to our hospital with a 
right infraorbital tumor and a history of previous excision 
of a bulky lesion in the same region 10 years previously; 
she was unaware of the pathologic diagnosis of the pre -
vious tumor.
The patient reported slow growth of the lesion, starting 
approximately 6 years previously. The lesion started to 
disrupt the visual field in the year before treatment, because 
of the bulging right lower eyelid. The patient denied the 
existence of comorbidities.
On physical examination, the tumor was oval and approxi-
mately 10 cm in diameter, with fibroelastic consistency. It was 
not tender to palpation, and it affected the entire right lower 
region of the eyelid causing significant proptosis (Figure 1). 
The tarsal senile laxity associated with the lesion’s excessive 
volume, which pulled the eyelid inferiorly, caused significant 
ectropion. Visual acuity was normal. The differential diag-
nosis of the lesion initially included lipoma, epidermoid cyst, 
and neurofibroma.
After the clinical preoperative examination, surgery was 
performed at the Hospital Irmã Dulce (Praia Grande, SP, 
Brazil) in order to remove the tumor. We found a single 
solid tumor, measuring approximately 10.2 × 9.7 × 9.2 cm, 
encapsulated in a blood-covered, very shiny surface that 
was be hind the orbicularis oculi. The lesion was resected 
and canthopexy was performed for correction of ectropion.
After resection, the diagnosis of vascular malforma tion 
was suggested, along with neurofibroma, schwannoma, and 
hemangiopericytoma. On histopathologic examination, 
the tumor consisted of cellular proliferation with mild pleo -
morphism, and exhibited a peculiar pattern characteri -
 zed by numerous angulated vessels interspersing tumor 
cells. Mitotic activity was mild and there was no evident 
necrosis. The diagnosis of hemangiopericytoma was made 
(Figure 2).
Despite the canthopexy, the patient developed swelling 
in the lower eyelid and tarsal region, along with ectropion. 
She refused any further treatment for the tumor (such as 
radiotherapy or chemotherapy), and continues to be followed 
up as an outpatient (Figure 3).
 Figure 1 – Preoperative appearance of the tumor,  
affecting the entire right lower eyelid.
A B C
Figure 2 – Histopathologic examination. In A, B, and C indicate 
cellular proliferation with mild pleomorphism, along with a 
characteristic vascular pattern, characterized by  
numerous vessels intercalated with tumor cells. 
Figure 3 – Postoperative appearance after tumor excision.
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DISCUSSION
Orbital hemangiopericytoma is generally a solid, slow-
gro wing tumor, without apparent predilection for race and 
gender. Although it preferentially affects adults between the 
third and sixth decades of life, it can also occur in children3,4.
Symptoms usually include slowly progressive unilateral 
proptosis, which may be accompanied by mild pain and 
de creased visual acuity5. It can be found anywhere in the 
orbit but has a predilection for the upper orbit. Although 
there may be benign biological behavior, there are reports 
of recurrences and metastases (lung, bone, and liver), with 
incidences of 43% and 15%, respectively, especially in cases 
where surgical excision is incomplete5-7. There is no way 
to predict, unequivocally, from histological examination, 
which tumors will exhibit more aggressive behavior8.
Imaging studies are not pathognomonic, but the tumor 
most often appears as a well-defined lesion that may or may 
not be enhanced with the use of contrast agents9. The diag -
nosis is confirmed by histopathologic examination and some-
times complemented by immnohistochemistry. 
The characteristic histopathology is cell proliferation 
with mild to moderate pleomorphism, arranged in bundles 
interspersed with numerous angulated vessels; on staining 
with reticulin, an apparent plot – isolating individual cells 
and vessels – is noted. On immunohistochemical study, 
the immunoreactivity of CD34 and factor VIII favors the 
diagnosis9-12.
With regard to treatment, there is unanimity on the need 
for complete excision with wide margins. Both radiotherapy 
and chemotherapy have shown controversial results, and are 
usually used only in cases of relapse6,13,14.
Radiotherapy and chemotherapy as initial treatments 
should be reserved for cases where surgical excision pre sents 
very high risk. In a retrospective study, Carew et al.15 reported 
a survival rate of 87.5% in a case series of 11 patients treated 
with total surgical excision, of whom, 4 received postope-
rative radiotherapy for having tumors histologically classi-
fied as high grade. Recurrences and distant metastases are 
rare in patients treated with complete surgical excision, but 
the majority of patients who had metastases or recurrences 
were diagnosed after more than 40 months follow-up, which 
suggests that the postoperative follow-up for all patients 
should be longer, regardless of the histological findings16.
Although it is rare, hemangiopericytoma should be con -
sidered in the differential diagnosis of well-defined orbital 
tumors along with epidermoid cysts, schwannomas, neuro-
fibromas, fibrous histiocytomas, lipomas, and vascular mal -
formations.
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